{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:34:13Z","timestamp":1791232453545,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T00:00:00Z","timestamp":1207180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T00:00:00Z","timestamp":1207180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1038\/leu.2008.79","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T10:02:36Z","timestamp":1207216956000},"page":"1106-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism"],"prefix":"10.1038","volume":"22","author":[{"given":"F","family":"Chiarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Del Sole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mongiorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G C","family":"Gaboardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Y","family":"Follo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"McCubrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,3]]},"reference":[{"key":"BFleu200879_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","volume":"55","author":"M Hennessy","year":"2007","unstructured":"Hennessy M, Spiers JP . A primer on the mechanics of P-glycoprotein the multidrug transporter. Pharmacol Res 2007; 55: 1\u201315.","journal-title":"Pharmacol Res"},{"key":"BFleu200879_CR2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/sj.leu.2404692","volume":"21","author":"D Steinbach","year":"2007","unstructured":"Steinbach D, Legrand O . ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia 2007; 21: 1172\u20131176.","journal-title":"Leukemia"},{"key":"BFleu200879_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE . Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48\u201358.","journal-title":"Nat Rev Cancer"},{"key":"BFleu200879_CR4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V93.3.1075","volume":"93","author":"RW Johnstone","year":"1999","unstructured":"Johnstone RW, Cretney E, Smyth MJ . P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 1999; 93: 1075\u20131085.","journal-title":"Blood"},{"key":"BFleu200879_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/sj.leu.2404539","volume":"21","author":"BC Medeiros","year":"2007","unstructured":"Medeiros BC, Landau HJ, Morrow M, Lockerbie RO, Pitts T, Eckhardt SG . The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines. Leukemia 2007; 21: 739\u2013746.","journal-title":"Leukemia"},{"key":"BFleu200879_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2006.09.018","volume":"250","author":"M Michaelis","year":"2007","unstructured":"Michaelis M, Cinatl J, Anand P, Rothweiler F, Kotchetkov R, Deimling A et al. Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells. Cancer Lett 2007; 250: 107\u2013116.","journal-title":"Cancer Lett"},{"key":"BFleu200879_CR7","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1158\/0008-5472.CAN-05-0575","volume":"65","author":"F Teraishi","year":"2005","unstructured":"Teraishi F, Wu S, Zhang L, Guo W, Davis JJ, Dong F et al. Identification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells. Cancer Res 2005; 65: 6380\u20136387.","journal-title":"Cancer Res"},{"key":"BFleu200879_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/sj.leu.2404245","volume":"20","author":"AM Martelli","year":"2006","unstructured":"Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C et al. Phosphoinositide 3-kinase\/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 2006; 20: 911\u2013928.","journal-title":"Leukemia"},{"key":"BFleu200879_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/sj.leu.2404643","volume":"21","author":"PL Tazzari","year":"2007","unstructured":"Tazzari PL, Tabellini G, Bortul R, Papa V, Evangelisti C, Grafone T et al. The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. Leukemia 2007; 21: 886\u2013896.","journal-title":"Leukemia"},{"key":"BFleu200879_CR10","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/sj.leu.2404813","volume":"21","author":"KT Doepfner","year":"2007","unstructured":"Doepfner KT, Spertini O, Arcaro A . Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase\/Akt pathway. Leukemia 2007; 21: 1921\u20131930.","journal-title":"Leukemia"},{"key":"BFleu200879_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC . AKT\/PKB signaling: navigating downstream. Cell 2007; 129: 1261\u20131274.","journal-title":"Cell"},{"key":"BFleu200879_CR12","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.4161\/cc.5.14.3005","volume":"5","author":"F Vazquez","year":"2006","unstructured":"Vazquez F, Devreotes P . Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 2006; 5: 1523\u20131527.","journal-title":"Cell Cycle"},{"key":"BFleu200879_CR13","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.1038\/sj.onc.1209088","volume":"24","author":"JQ Cheng","year":"2005","unstructured":"Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV . The Akt\/PKB pathway: molecular target for cancer drug discovery. Oncogene 2005; 24: 7482\u20137492.","journal-title":"Oncogene"},{"key":"BFleu200879_CR14","first-page":"1093","volume":"2","author":"SB Kondapaka","year":"2003","unstructured":"Kondapaka SB, Singh SS, Dasmahapatra GP, Sausville EA, Roy KK . Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol Cancer Ther 2003; 2: 1093\u20131103.","journal-title":"Mol Cancer Ther"},{"key":"BFleu200879_CR15","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1158\/1078-0432.CCR-03-0406","volume":"10","author":"L Van Ummersen","year":"2004","unstructured":"Van Ummersen L, Binger K, Volkman J, Marnocha R, Tutsch K, Kolesar J et al. A phase I trial of perifosine (NSC 639966) on a loading dose\/maintenance dose schedule in patients with advanced cancer. Clin Cancer Res 2004; 10: 7450\u20137456.","journal-title":"Clin Cancer Res"},{"key":"BFleu200879_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1182\/blood-2006-04-016824","volume":"109","author":"C Gajate","year":"2007","unstructured":"Gajate C, Mollinedo F . Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood 2007; 109: 711\u2013719.","journal-title":"Blood"},{"key":"BFleu200879_CR17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/S0959-8049(02)00127-2","volume":"38","author":"M Crul","year":"2002","unstructured":"Crul M, Rosing H, de Klerk GJ, Dubbelman R, Traiser M, Reichert S et al. Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours. Eur J Cancer 2002; 38: 1615\u20131621.","journal-title":"Eur J Cancer"},{"key":"BFleu200879_CR18","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1158\/1535-7163.MCT-07-0004","volume":"6","author":"HA Elrod","year":"2007","unstructured":"Elrod HA, Lin YD, Yue P, Wang X, Lonial S, Khuri FR et al. The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway. Mol Cancer Ther 2007; 6: 2029\u20132038.","journal-title":"Mol Cancer Ther"},{"key":"BFleu200879_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/1078-0432.CCR-05-1654","volume":"12","author":"CA Granville","year":"2006","unstructured":"Granville CA, Memmott RM, Gills JJ, Dennis PA . Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase\/Akt\/mammalian target of rapamycin pathway. Clin Cancer Res 2006; 12: 679\u2013689.","journal-title":"Clin Cancer Res"},{"key":"BFleu200879_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1158\/1535-7163.MCT-06-0076","volume":"5","author":"M Nyakern","year":"2006","unstructured":"Nyakern M, Cappellini A, Mantovani I, Martelli AM . Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol Cancer Ther 2006; 5: 1559\u20131570.","journal-title":"Mol Cancer Ther"},{"key":"BFleu200879_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/jcp.20628","volume":"207","author":"I Mantovani","year":"2006","unstructured":"Mantovani I, Cappellini A, Tazzari PL, Papa V, Cocco L, Martelli AM . Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. J Cell Physiol 2006; 207: 836\u2013844.","journal-title":"J Cell Physiol"},{"key":"BFleu200879_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.leu.2404980","volume":"22","author":"V Papa","year":"2008","unstructured":"Papa V, Tazzari PL, Chiarini F, Cappellini A, Ricci F, Billi AM et al. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. Leukemia 2008; 22: 147\u2013160.","journal-title":"Leukemia"},{"key":"BFleu200879_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ctrv.2006.12.001","volume":"33","author":"SR Vink","year":"2007","unstructured":"Vink SR, van Blitterswijk WJ, Schellens JH, Verheij M . Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. Cancer Treat Rev 2007; 33: 191\u2013202.","journal-title":"Cancer Treat Rev"},{"key":"BFleu200879_CR24","doi-asserted-by":"publisher","first-page":"30520","DOI":"10.1074\/jbc.M004630200","volume":"275","author":"I Faenza","year":"2000","unstructured":"Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D et al. A role for nuclear phospholipase Cbeta 1 in cell cycle control. J Biol Chem 2000; 275: 30520\u201330524.","journal-title":"J Biol Chem"},{"key":"BFleu200879_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.leu.2404523","volume":"21","author":"PL Tazzari","year":"2007","unstructured":"Tazzari PL, Cappellini A, Ricci F, Evangelisti C, Papa V, Grafone T et al. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 2007; 21: 427\u2013438.","journal-title":"Leukemia"},{"key":"BFleu200879_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.bbrc.2004.06.038","volume":"320","author":"S Uddin","year":"2004","unstructured":"Uddin S, Hussain A, Al-Hussein K, Platanias LC, Bhatia KG . Inhibition of phosphatidylinositol 3\u2032-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway. Biochem Biophys Res Commun 2004; 320: 932\u2013938.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu200879_CR27","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1182\/blood-2005-08-3434","volume":"107","author":"T Hideshima","year":"2006","unstructured":"Hideshima T, Catley L, Yasui H, Ishitsuka K, Raje N, Mitsiades C et al. Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood 2006; 107: 4053\u20134062.","journal-title":"Blood"},{"key":"BFleu200879_CR28","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1182\/blood-2003-10-3720","volume":"104","author":"N Shah","year":"2004","unstructured":"Shah N, Asch RJ, Lysholm AS, Lebien TW . Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor. Blood 2004; 104: 2873\u20132878.","journal-title":"Blood"},{"key":"BFleu200879_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0959-440X(96)80110-2","volume":"6","author":"C Ostermeier","year":"1996","unstructured":"Ostermeier C, Iwata S, Michel H . Cytochrome c oxidase. Curr Opin Struct Biol 1996; 6: 460\u2013466.","journal-title":"Curr Opin Struct Biol"},{"key":"BFleu200879_CR30","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1021\/bi00438a017","volume":"28","author":"A Schon","year":"1989","unstructured":"Schon A, Freire E . Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. Biochemistry 1989; 28: 5019\u20135024.","journal-title":"Biochemistry"},{"key":"BFleu200879_CR31","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1182\/blood.V98.13.3860","volume":"98","author":"C Gajate","year":"2001","unstructured":"Gajate C, Mollinedo F . The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas\/CD95 into membrane rafts in human leukemic cells. Blood 2001; 98: 3860\u20133863.","journal-title":"Blood"},{"key":"BFleu200879_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1089\/dna.1991.10.639","volume":"10","author":"M Ikeguchi","year":"1991","unstructured":"Ikeguchi M, Teeter LD, Eckersberg T, Ganapathi R, Kuo MT . Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3\/mdr1a reveal a negative element containing the AP-1 binding site. DNA Cell Biol 1991; 10: 639\u2013649.","journal-title":"DNA Cell Biol"},{"key":"BFleu200879_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/0008-5472.CAN-05-1779","volume":"66","author":"J Zhou","year":"2006","unstructured":"Zhou J, Liu M, Aneja R, Chandra R, Lage H, Joshi HC . Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res 2006; 66: 445\u2013452.","journal-title":"Cancer Res"},{"key":"BFleu200879_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.4161\/cbt.5.7.2874","volume":"5","author":"A Argiris","year":"2006","unstructured":"Argiris A, Cohen E, Karrison T, Esparaz B, Mauer A, Ansari R et al. A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Cancer Biol Ther 2006; 5: 766\u2013770.","journal-title":"Cancer Biol Ther"},{"key":"BFleu200879_CR35","first-page":"4527","volume":"63","author":"ZH Miao","year":"2003","unstructured":"Miao ZH, Ding J . Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res 2003; 63: 4527\u20134532.","journal-title":"Cancer Res"},{"key":"BFleu200879_CR36","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s00018-005-5554-9","volume":"63","author":"S Orlowski","year":"2006","unstructured":"Orlowski S, Martin S, Escargueil A . P-glycoprotein and \u2018lipid rafts\u2019: some ambiguous mutual relationships (floating on them, building them or meeting them by chance? Cell Mol Life Sci 2006; 63: 1038\u20131059.","journal-title":"Cell Mol Life Sci"},{"key":"BFleu200879_CR37","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1124\/mol.104.002329","volume":"66","author":"J Troost","year":"2004","unstructured":"Troost J, Lindenmaier H, Haefeli WE, Weiss J . Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells. Mol Pharmacol 2004; 66: 1332\u20131339.","journal-title":"Mol Pharmacol"},{"key":"BFleu200879_CR38","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1158\/1535-7163.MCT-07-0202","volume":"6","author":"AH van der Luit","year":"2007","unstructured":"van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M et al. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther 2007; 6: 2337\u20132345.","journal-title":"Mol Cancer Ther"},{"key":"BFleu200879_CR39","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1182\/blood-2005-03-0929","volume":"106","author":"R Avellino","year":"2005","unstructured":"Avellino R, Romano S, Parasole R, Bisogni R, Lamberti A, Poggi V et al. Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood 2005; 106: 1400\u20131406.","journal-title":"Blood"},{"key":"BFleu200879_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1182\/blood-2001-12-0371","volume":"100","author":"A Tafuri","year":"2002","unstructured":"Tafuri A, Gregorj C, Petrucci MT, Ricciardi MR, Mancini M, Cimino G et al. MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 2002; 100: 974\u2013981.","journal-title":"Blood"},{"key":"BFleu200879_CR41","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/sj.leu.2404740","volume":"21","author":"J Yang","year":"2007","unstructured":"Yang J, Liu J, Zheng J, Du W, He Y, Liu W et al. A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia. Leukemia 2007; 21: 2072\u20132074.","journal-title":"Leukemia"},{"key":"BFleu200879_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2005-04-1754","volume":"107","author":"A Vitale","year":"2006","unstructured":"Vitale A, Guarini A, Ariola C, Mancini M, Mecucci C, Cuneo A et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood 2006; 107: 473\u2013479.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200879","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:23:23Z","timestamp":1648729403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,3]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["BFleu200879"],"URL":"https:\/\/doi.org\/10.1038\/leu.2008.79","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,3]]},"assertion":[{"value":"18 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}